Please login to the form below

Frontera Group

We are one of the world's leading patient-activation groups.

We comprise of a digital insight consultancy, creative activation agency. Within our team we have experts in the field of behavioural science and its application to address health challenges.

We have developed a range of products and methodologies that help clients to navigate the challenges they face. Whether that's how to co-create with disease communities, remotely engage audiences during COVID, or how to run creative innovation sessions with internal teams - we have an approach and the experience to help make positive change happen.

Areas of Expertise

CHANGE SOMETHING

REDLINE STRATEGIC

We immerse clients in the world of the patient, to ensure your insights & strategies are based on the people you treat. www.redlinestrategic.com

  • PATH: mapping patient disease & treatment journey
  • SWARM: mobile-enabled ethnography
  • SPOTLIGHT: Social listening & needs analytsis
  • NEST: Co-creation with online communities
  • CLUSTER: Positioning determination, persona development, establishing pQuant analysis (HC / PCA) with digital surveying
  • TDF behaviour decoding
  • COM-B behavioural analysis
  • HACKATHON: events with disease communities
  • MAP: market and competitor analysis
  • PREDICT: Trends and correlations in health

FRONTERA LONDON

We immerse clients in the world of the patient, to ensure the patient voice can be heard loud & clear throughout your communication. www.fronteralondon.com

  • Disease awareness programmes
  • Launch and promotional campaign
  • REMOTE: COVID-proof suite of self-led video engagement tools
    • STING - brand / diseases modules
    • PRECIS - clinical study modules
    • CASE - patient/physician case modules
  • PSP: Patient support programming
  • UX/UI: design development & user testing
  • Digital patient starter kits
  • Pilot development with disease communities
  • Interactive case-based learning modules
  • Internal company innovation workshops

Corporate Social Responsibility

We believe in having a purpose, for our organisation to make a positive impact on the world.

Our focus is to use the specific set of skills to help improve the oputcomes of the patients we serve through each and everyone of our audiences. Because for frontera, patients really are at the centre of our thinking. And when we improve outcoms for patients, everybody wins.

Clients

AbbVie
Actavis 
Alimera Sciences
Allergan 
Amgen
AstraZeneca
Bayer
Boehringer Ingelheim
Dreamskin Health 
Eusa Pharma

Fresenius Kabi
Galderma 
Gedeon Richter
Genzyme
Grunenthal 
Leukaemia UK
Medskin Solutions 
Menarini Farmaceutica Internazionale 
Merck
Merz Pharmaceuticals
Mitsubishi Pharma Europe
Novartis Pharmaceuticals
Pfizer
Shire Pharmaceuticals
UCB 
Vertex Pharmaceuticals

Team

Craig Mills
Group Managing Director, Frontera Group
craig@frontera-group.com
View LinkedIn profile
Dani Verrall
Managing Partner, Frontera London
dani@fronteralondon.com
View LinkedIn profile
Rachel David
Managing Partner, Redline Strategic
rachel.david@redlinestrategic.com
View LinkedIn profile
Emma Langley
Head of Content, Frontera London
emma.langley@fronteralondon.com
View LinkedIn profile
Mark Frost
Creative Director, Frontera London
mark.frost@fronteralondon.com
View LinkedIn profile
Rachel Dyer
HR Lead, Frontera Group
hr@frontera-group.com
View LinkedIn profile
Chalo Ypes
Group Finance Lead, Frontera Group
finance@frontera-group.com
Dr Hannah Betts
Research Consultant
hannah.betts@redlinestrategic.com
View LinkedIn profile

Press Releases

Frontera Group continues growth

Frontera London, part of the Frontera Group, is delighted to announce the additions of Emma Langley and Mark Frost to the senior leadership team.

Proud Finalists

Frontera capped off a terrific year by being a finalist for consultancy of the year.

Frontera proud finalists for the 2020 PM Awards
5 category nominations, a great end to a fantastic year
FRONTERA GROUP LAUNCHES NEW mHEALTH PROVIDER, STIKKE
Frontera Group expands its offering with the launch of Stikke, a new business created specifically to focus on the value mobile health can bring to patients.
Big wins for Frontera at the 2016 PM Awards

White Papers and Resources

>> FAST FORWARD How pandemics accelerate new thinking and early adoption in healthcare.

Spanish Flu killed > 2% of the world, but accelerated healthcare for all. HOW is COVID-19 accelerating healthcare again and WHY does evidence say being an innovator matters?

The other side of ... gout
Frontera wins at IPA Best of Health 2016
Why Don't More People Want to Change the World?

Healthcare is critical. But healthcare will never be fixed to a point where we can say that it's done. Instead, it's about looking at things in new ways, exploring new ideas for changing behaviour to improve outcomes. For everyone. So, why don't more people try to do different?

Patient Truth is Out There

Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what do we stand to gain by really listening to patients?  We spoke to patients, academics, Pharma, not-for-profit and industry professionals to find out the value of the patient voice. The power it holds to transform health outcomes, which benefits not only the healthcare system but also the pharmaceutical industry.  Download our white paper and explore:  What people mean when they talk about patient centricity The benefits of listening to patients – for patients, Pharma and the healthcare system as a whole The challenges to capturing the patient voice and how technology can help deliver it How Pharma should evolve its practices to drive patient activation

Culture Club: Supporting company goals, values and practices through COVID

Company culture is more tangible than values. It feeds positive employee engagement and is a blueprint for success. It sets foundations for growth and results. During COVID it’s needed more than ever.

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed...
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?

The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint in this week's instalment of our Pharma and COVID-19 series by Rare Immunology Global Medical Lead Karen Cheng

The other side of … blood cancer

To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision.

Healthcare in a lockdown

Even if patients are getting enough care during the COVID-19 pandemic, are they getting the right care?

The other side of … multiple sclerosis
No good comes from excluding patients from having a say in their own care. In fact, improving activation (& outcomes) demands it.
The other side of … Crohn’s disease

What patients say is their truth about living with chronic conditions. “I want to believe in my doctor but I feel more comfortable getting my guidance elsewhere.”

1000 Voices Survey

The patient voice is key to creating meaningful changes in healthcare; to drive patients to be more actively involved in their care, which leads to better outcomes. So, we went to patients and asked them their views on how being actively involved they are...

The truth is out there: Patients first
Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what do we stand to gain by really listening to patients?
mHealth: The revolution will not be digital
Could mHealth, which has been growing exponentially in recent years, be the answer we have been looking for to address our population health challenge? Could mHealth save healthcare?
New partnership with ELF in 2017
Are you free to think?
Creating a culture to target differentiation in health...
Deploy...
Design...
Decode...
When data are not enough...
Don't you forget about me...
Creating a culture to target differentiation in health...
Digital is dead. Long live digital!

Videos and Podcasts

Facebook

Testimonials

"The rare disease project has really transformed the Sanofi Genzyme rare disease franchise. What started out as a small project in one disease area to support a product launch has cascaded across all the rare disease brands, and has fundamentally changed how we interact with our customers in sales calls.”

Tom Rigden, Marketing Manager, Rare Disease Portfolio - Sanofi

"I had the pleasure of working with Frontera across a number of projects, where the challenge was oriented around issue of diagnosis in rare disease. I found their approach using behavioural engineering to be innovative and effective, especially when considering the problems in effective patient communication."

Tomas Lännhult, Global Brand Lead - Novo Nordisk

Networks

Bloc Partners

Company Details

Frontera Group

+44 (0) 7817 410079

Contact Website

Address:
St. John’s House
54 St. John’s Square
London
EC1V 4JL

Latest content on this profile

Frontera Group continues growth
Frontera London, part of the Frontera Group, is delighted to announce the additions of Emma Langley and Mark Frost to the senior leadership team.
Frontera Group
>> FAST FORWARD How pandemics accelerate new thinking and early adoption in healthcare.
Spanish Flu killed > 2% of the world, but accelerated healthcare for all. HOW is COVID-19 accelerating healthcare again and WHY does evidence say being an innovator matters?
Frontera Group
The other side of ... gout

Frontera Group
Frontera wins at IPA Best of Health 2016

Frontera Group
Why Don't More People Want to Change the World?
Healthcare is critical. But healthcare will never be fixed to a point where we can say that it's done. Instead, it's about looking at things in new ways, exploring new ideas for changing behaviour to improve outcomes. For everyone. So, why don't more people try to do different?
Frontera Group
Patient Truth is Out There
Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what do we stand to gain by really listening to patients?  We spoke to patients, academics, Pharma, not-for-profit and industry professionals to find out the value of the patient voice. The power it holds to transform health outcomes, which benefits not only the healthcare system but also the pharmaceutical industry.  Download our white paper and explore:  What people mean when they talk about patient centricity The benefits of listening to patients – for patients, Pharma and the healthcare system as a whole The challenges to capturing the patient voice and how technology can help deliver it How Pharma should evolve its practices to drive patient activation
Frontera Group